Page 35 - Flow Cytometry News Today

Researchers conducted a detailed epitope mapping of Np and developed an experimental double antigen-based ELISA.

In the present study, researchers isolated an infectious AY.4.2 strain of COVID-19 from the nasopharyngeal swab of a symptomatic individual from the Paris region. Then, they introduced the AY.4.2 signature mutations - T95I, Y145H, and A222V - in an expression plasmid coding the Delta protein to study the function of the AY.4.2 S protein.

 Rapid developments in cell biology continue to fuel the growth of flow cytometry market. Moreover, rise in chronic diseases such as cancer accentuates the demand for flow cytometry. Augmented demand for flow cytometry in studying protein-protein interaction, fluorescent protein detection, tumor characterization, an...

New research can confirm that while some of the response from monocytes to SARS-CoV-2 is generic to virus infection, most of it SARS-CoV-2 specific, especially proinflammatory responses.

/PRNewswire/ -- Piramal Pharma Limiteds Pharma Solutions (PPS) business, a leading Contract Research, Development and Manufacturing Organization (CDMO), today...

- Multi-million dollar investment augments in-vitro biology capabilities in primary and secondary screening - Brings added value to customers by coupling biology services with existing

Piramal Pharma Solutions expands In Vitro biology capabilities at Ahmedabad site

/PRNewswire/ -- Piramal Pharma Limiteds Pharma Solutions (PPS) business, a leading Contract Research, Development and Manufacturing Organization (CDMO), today...

In a new study, researchers from New York University have been examining the ability of defensosomes to combat SARS-CoV-2 infection.

Researchers demonstrate that the exposure of platelets to the SARS-CoV-2 spike protein promotes their activation and adhesion.